Transparency Life Sciences is the world’s first drug development company based on open innovation. Our goal is to develop medicines for significant unmet medical needs by acquiring promising drug compounds, designing studies via crowdsourced methods, and conducting those clinical studies with unmatched productivity.
Researchers, patients, and drug developers: we need your input. Please join our global community dedicated to delivering safe drugs into the hands of patients who need them via dramatically lower-cost clinical trials.
United States of America, New York, Boston, Palo Alto
Company contact details
For more information on how to get involved, please contact CEO Tomasz Sablinski at: firstname.lastname@example.org.
Please direct all investor and partnership inquires to COO Marc Foster at: email@example.com
Brief business history
Developed in 2011 and launched in January 2012, Transparency Life Sciences is the product of industry veterans' belief that the pharmaceutical industry can be streamlined through harnessing the power of collaborative intelligence. Its founders have witnessed firsthand the inefficiencies of pharmaceutical research, and they created the TLS platform with the intention of lowering the cost of drugs for both the researcher and the patient.